AppsFromResearch
My Weight Loss Journey icon

My Weight Loss Journey

Evidence Tier:CLINICAL GRADE

Validated in clinical trials

For:Patients & Caregivers

App Summary

My Weight Loss Journey is an application for patients considering bariatric surgery that provides personalized estimates of surgical risks, complications, and weight loss to support shared decision-making with their clinical team. The app's risk calculator was developed from a registry of over 25,000 patients and its predictions have been validated in subsequent studies, with a validation study (N=276) in a Hispanic population demonstrating strong agreement between expected and actual weight loss. The associated research concludes that this empirically-based risk calculator can improve the informed consent process and support shared decision-making between patients and surgeons.

App Screenshots

My Weight Loss Journey screenshot 1 of 26My Weight Loss Journey screenshot 2 of 26My Weight Loss Journey screenshot 3 of 26My Weight Loss Journey screenshot 4 of 26My Weight Loss Journey screenshot 5 of 26My Weight Loss Journey screenshot 6 of 26My Weight Loss Journey screenshot 7 of 26My Weight Loss Journey screenshot 8 of 26My Weight Loss Journey screenshot 9 of 26My Weight Loss Journey screenshot 10 of 26My Weight Loss Journey screenshot 11 of 26My Weight Loss Journey screenshot 12 of 26My Weight Loss Journey screenshot 13 of 26My Weight Loss Journey screenshot 14 of 26My Weight Loss Journey screenshot 15 of 26My Weight Loss Journey screenshot 16 of 26My Weight Loss Journey screenshot 17 of 26My Weight Loss Journey screenshot 18 of 26My Weight Loss Journey screenshot 19 of 26My Weight Loss Journey screenshot 20 of 26My Weight Loss Journey screenshot 21 of 26My Weight Loss Journey screenshot 22 of 26My Weight Loss Journey screenshot 23 of 26My Weight Loss Journey screenshot 24 of 26My Weight Loss Journey screenshot 25 of 26My Weight Loss Journey screenshot 26 of 26

Detailed Description

Functionality & Mechanism

Developed by the University of Michigan and the Michigan Bariatric Surgery Collaborative (MBSC), this application provides tailored risk and benefit estimates for bariatric surgery. The system captures patient data—including demographics, medical history, and procedural preference—via a survey interface. It then generates graphical visualizations of potential outcomes (weight loss, comorbidity resolution) and complications for sleeve gastrectomy and Roux-en-Y gastric bypass. The platform also integrates modules for longitudinal weight tracking and patient engagement through personalized check-ins.

Evidence & Research Context

  • The app's proprietary risk/benefit calculator is derived from a prospective, externally-audited clinical registry of over 25,000 patients maintained by the Michigan Bariatric Surgery Collaborative.
  • Associated research identified and modeled significant predictors for serious complications (e.g., age, coronary artery disease, mobility limitations) and venous thromboembolism (VTE).
  • A validation study (N=276) in a U.S. Hispanic population demonstrated strong agreement between the calculator's predicted weight and patients' actual weight at one year post-surgery (concordance correlation coefficient = .80).
  • An external validation study in a Dutch population (N=51,291) confirmed the serious complication model has good calibration, though it showed moderate discrimination (AUC=.602).

Intended Use & Scope

This tool is intended for patients considering bariatric surgery, in collaboration with their clinical care teams. Its primary utility is to facilitate shared decision-making and enhance the informed consent process by providing personalized outcome estimates. The app is not a substitute for clinical consultation and does not provide medical advice or treatment recommendations.

Studies & Publications

5 publications

Peer-reviewed research associated with this app.

Validation Study

Validation of the Michigan Bariatric Surgery Collaborative outcomes calculator in a Hispanic population

Chaudhry et al. (2025) · Surgery for Obesity and Related Diseases

Calculator accurately predicted weight loss outcomes in Hispanic bariatric surgery patients.

Background The Michigan Bariatric Surgery Collaborative (MBSC) has developed an app that calculates outcomes, to include predicted weight loss and venous thromboembolism rates. The app is called Weigh the Odds. This app provides an important method for discussing outcomes with patients. Objectives We sought to determine the validity of the MBSC outcomes calculator in a Hispanic population. Setting Community practice in Texas. Methods A community practice with a large percentage of Hispanic patients was used to validate the MBSC calculator. The correlation coefficient was calculated. A chi-square test was used to compare quantitative variables between the operation types. Lin's concordance correlation along with the Bland-Altman plot were performed to estimate the level of agreement between actual and expected weights at 1 year. Results Two hundred seventy-six patients met the eligibility criteria and were included in the study. The average body mass index (BMI) at the time of initial bariatric surgery was 45.2 kg/m2 (standard deviation [SD], 6.68). One hundred seventy-seven patients underwent sleeve gastrectomy (SG), and 99 patients underwent Roux-en-Y gastric bypass (RYGB) as their initial bariatric operation. The mean actual weight at 1 year for the entire cohort was 90.8 kg (SD, 19.6), while the mean expected weight was 89.2 kg (SD, 16.9), leading to a mean difference of 1.6 kg. The concordance correlation coefficient of .80 (95% CI: .76-.84, P < .001) demonstrates a strong agreement between actual and expected weights at 1 year. There was a lower correlation coefficient for RYGB patients. Conclusion The concordance correlation coefficient demonstrated a strong agreement between actual and expected weights at 1 year. These findings validate the MBSC outcomes calculator in a Hispanic population.
... Read More
Validation Study

Predicting serious complication risks after bariatric surgery: external validation of the Michigan Bariatric Surgery Collaborative risk prediction model using the Dutch Audit for Treatment of Obesity

Akpinar et al. (2022) · Surgery for Obesity and Related Diseases

Model showed good calibration but only moderate ability to predict serious complication risks.

Background Risk-prediction tools can support doctor–patient (shared) decision making in clinical practice by providing information on complication risks for different types of bariatric surgery. However, external validation is imperative to ensure the generalizability of predictions in a new patient population. Objective To perform an external validation of the risk-prediction model for serious complications from the Michigan Bariatric Surgery Collaborative (MBSC) for Dutch bariatric patients using the nationwide Dutch Audit for Treatment of Obesity (DATO). Setting Population-based study, including all 18 hospitals performing bariatric surgery in the Netherlands. Methods All patients registered in the DATO undergoing bariatric surgery between 2015 and 2020 were included as the validation cohort. Serious complications included, among others, abdominal abscess, bowel obstruction, leak, and bleeding. Three risk-prediction models were validated: (1) the original MBSC model from 2011, (2) the original MBSC model including the same variables but updated to more recent patients (2015–2020), and (3) the current MBSC model. The following predictors from the MBSC model were available in the DATO: age, sex, procedure type, cardiovascular disease, and pulmonary disease. Model performance was determined using the area under the curve (AUC) to assess discrimination (i.e., the ability to distinguish patients with events from those without events) and a graphical plot to assess calibration (i.e., whether the predicted absolute risk for patients was similar to the observed prevalence of the outcome). Results The DATO validation cohort included 51,291 patients. Overall, 986 patients (1.92%) experienced serious complications. The original MBSC model, which was extended with the predictors "GERD (yes/no)," "OSAS (yes/no)," "hypertension (yes/no)," and "renal disease (yes/no)," showed the best validation results. This model had a good calibration and an AUC of .602 compared with an AUC of .65 and moderate to good calibration in the Michigan model. Conclusion The DATO prediction model has good calibration but moderate discrimination. To be used in clinical practice, good calibration is essential to accurately predict individual risks in a real-world setting. Therefore, this model could provide valuable information for bariatric surgeons as part of shared decision making in daily practice.
... Read More

My Weight Loss Journey

Free